Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
1.770
+0.500 (39.37%)
At close: Mar 24, 2025
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $57.30 million as of September 18, 2025.
Market Cap
57.30M
Enterprise Value
57.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.77
Market Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 9.76M to 57.30M, an increase of 487.06%. That is a compound annual growth rate of 27.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 24, 2025 | 57.30M | 179,053,646.88% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 1,045.91% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 782.91M |
| Elite Pharmaceuticals | 735.19M |
| Glass House Brands | 548.40M |
| Northwest Biotherapeutics | 379.14M |
| American Oncology Network | 353.52M |
| CytoDyn | 351.92M |